RxDoctor Payments Data

Elliot Frohman

Neurology · Austin, TXNPI 1689630147

Payments from drug & device makers

$380,935in general payments, 2019–2025

Across 378 payments — averaging $1007.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$132K
  • AstraZeneca$89K
  • Johnson & Johnson$60K
  • Vanda Pharmaceuticals Inc.$50K
  • Novartis$21K
  • Amgen$10K
  • plus $18K from 6 others

What the payments were for

  • Consulting fees$25,9607%
  • Speaking & faculty fees$297,26978%
  • Travel & lodging$50,28613%
  • Food & beverage$7,4212%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$380,935 in reported general payments places this provider in the 90th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Other neurology in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →